Patterns of use of hormone replacement therapy in one million women in Britain, 1996-2000

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 109, Issue 12, 2002, Pages 1319-1330

  Abbott, Simon ^a   Bailey, Emma ^a   Baker, Krys ^a   Banks, Emily ^a   Barnes, Isobel ^a   Balkwill, Angela ^a   Beral, Valerie ^a   Black, Judith ^a   Bonner, Kate ^a   Brown, Anna ^a   Bull, Diana ^a   Burrile, Andrea ^a   Cameron, Becky ^a   Clarke, Judith ^a   Cliff, Andrea ^a   Crossley, Barbara ^a   Dee, Jane ^a   Eastwood, David ^a   Ewart, Dave ^a   Gerrard, Laura ^a   Green, Jane ^a   Hilton, Elizabeth ^a   Hogg, Ann ^a   Hooley, Joy ^a   Hurst, Anna ^a   Keene, Carol ^a   Kennedy, Caroline ^a   Langston, Nicky ^a   Lewis, Christine ^a   Mathie, Joanne ^a   Pennington, Karen ^a   Reeves, Gillian ^a   Reid, Simon ^a   Roden, Brian ^a   Sherman, Emma ^a   Simmonds, Moya ^a   Spencer, Elizabeth ^a   Timadjer, Alison ^a   Warby, Steve ^a   Austoker, Joan ^a   English, Ruth ^a   Patnick, Julietta ^a   Peto, Richard ^a   Vessey, Martin ^a   Wallis, Matthew ^a   more..

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; GESTAGEN;

ADULT; ALCOHOL CONSUMPTION; ANAMNESIS; ARTICLE; BODY MASS; BREAST CARCINOMA; CONTROLLED STUDY; DIABETES MELLITUS; DRUG USE; EXERCISE; FEMALE; GYNECOLOGIC SURGERY; HEART DISEASE; HORMONE SUBSTITUTION; HUMAN; HYPERTENSION; HYSTERECTOMY; LIFESTYLE; MAJOR CLINICAL STUDY; OVARIECTOMY; POPULATION RESEARCH; PRIORITY JOURNAL; SMOKING; SOCIOECONOMICS; STROKE; THROMBOEMBOLISM; UNITED KINGDOM;

AGE DISTRIBUTION; ENGLAND; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; HYSTERECTOMY; LOGISTIC MODELS; MIDDLE AGED; OVARIECTOMY; PREVALENCE; REGRESSION ANALYSIS; SCOTLAND; TIME FACTORS;

EID: 0036919218     PISSN: 14700328     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-0528.2002.02214.x     Document Type: Article

References (22)

1. Beral V., Banks E., Reeves G., Appleby P.N. Use of HRT and the subsequent risk of cancer. J Epidemiol Biostat. 4:1999;191-215.
2. The Million Women Study: design and characteristics of the study population. Breast Cancer Res. 1:1999;73-80.
3. British Medical Association and the Royal Pharmaceutical Society of Great Britain. British National Formulary. London: BMJ Books and Wallingford: Pharmaceutical Press, 1999:37.
4. Townsend P., Phillimore P., Beattie A. Health and Deprivation: Inequality and the North. 1988;Croom Helm, London.
5. Stata Statistical Software: Release 5.0. 1997;Stata, College Station, Texas.
6. Banks E., Beral V., Cameron Ret al. Agreement between general practice prescription data and self-reported use of hormone replacement therapy and treatment for various illnesses. J Epidemiol Biostat. 6:2001;357-363.
7. Banks E., Beral V., Cameron Ret al. Comparison of various characteristics of women who do and do not attend for breast cancer screening. Breast Cancer Res. 4:2002;R1.1-R1.6.
8. Office for National Statistics. Key Health Statistics from General Practice 1998. Series MB6 (No. 2). London: National Statistics, 2000.
9. Sinclair H.K., Bond C.M., Taylor R.J. Hormone replacement therapy: a study of women's knowledge and attitudes. Br J Gen Pract. 43:1993;365-370.
10. Spector T.D. Use of oestrogen replacement therapy in high risk groups in the United Kingdom. BMJ. 299:1989;1434-1435.
11. Lancaster T., Surman G., Lawrence Met al. Hormone replacement therapy: characteristics of users and non-users in a British general practice cohort identified through computerised prescribing records. J Epidemiol Community Health. 49:1995;389-394.
12. Derby C.A., Hume A.L., Barbour M.M., McPhillips J.B., Lasater T.M., Carleton R.A. Correlates of postmenopausal estrogen use and trends through the 1980s in two southeastern New England communities. Am J Epidemiol. 137:1993;1125-1135.
13. Moorhead T., Hannaford P., Warskyi M. Prevalence and characteristics associated with use of hormone replacement therapy in Britain. Br J Obstet Gynaecol. 104:1997;290-297.
14. Lawrence M., Jones L., Lancaster T., Daly E., Banks E. Hormone replacement therapy: patterns of use studied through British general practice computerized records. Fam Pract. 16:1999;335-342.
15. Kuh D.L., Wadsworth M., Hardy R. Women's health in midlife: the influence of the menopause, social factors and health in earlier life. Br J Obstet Gynaecol. 104:1997;923-933.
16. Barrett Connor E., Brown W.V., Turner J., Austin M., Criqui M.H. Heart disease risk factors and hormone use in postmenopausal women. JAMA. 241:1979;2167-2169.
17. Nabulsi A.A., Folsom A.R., White Aet al. Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women. The Atherosclerosis Risk in Communities Study Investigators. N Engl J Med. 328:1993;1069-1075.
18. Matthews K.A., Kuller L.H., Wing R.R., Meilahn E.N., Plantinga P. Prior to use of estrogen replacement therapy, are users healthier than nonusers? Am J Epidemiol. 143:1996;971-978.
19. Rodstom K., Bengtsson C., Lissner L., Bjorkelund C. Pre-existing risk factor profiles in users and non-users of hormone replacement therapy: prospective cohort study in Gothenberg, Sweden. BMJ. 319:1999;890-893.
20. Harris T.J., Cook D.G., Wicks P.D., Cappuccio F.P. Ethnic differences in use of hormone replacement therapy: community based survey. BMJ. 319:1999;610-611.
21. Harris R.B., Laws A., Reddy V.M., King A., Haskell W.L. Are women using postmenopausal estrogens? A community survey. Am J Public Health. 80:1990;1266-1268.
22. Maniolo T.A., Furberg C.D., Shemanski Let al. Associations of postmenopausal estrogen use with cardiovascular disease and its risk factors in older women. Circulation. 88:1993;2163-2171.